Zhang, J.; Wang, X.; Wang, R.; Chen, G.; Wang, J.; Feng, J.; Li, Y.; Yu, Z.; Xiao, H.
Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation. Biomedicines 2023, 11, 949.
https://doi.org/10.3390/biomedicines11030949
AMA Style
Zhang J, Wang X, Wang R, Chen G, Wang J, Feng J, Li Y, Yu Z, Xiao H.
Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation. Biomedicines. 2023; 11(3):949.
https://doi.org/10.3390/biomedicines11030949
Chicago/Turabian Style
Zhang, Jilu, Xun Wang, Renxi Wang, Guojiang Chen, Jing Wang, Jiannan Feng, Yan Li, Zuyin Yu, and He Xiao.
2023. "Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation" Biomedicines 11, no. 3: 949.
https://doi.org/10.3390/biomedicines11030949
APA Style
Zhang, J., Wang, X., Wang, R., Chen, G., Wang, J., Feng, J., Li, Y., Yu, Z., & Xiao, H.
(2023). Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation. Biomedicines, 11(3), 949.
https://doi.org/10.3390/biomedicines11030949
